Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytodiagnosis | 16 | 2024 | 450 | 4.540 |
Why?
|
Lung Neoplasms | 61 | 2024 | 13485 | 3.490 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 27 | 2023 | 5387 | 2.360 |
Why?
|
Biopsy, Fine-Needle | 20 | 2024 | 1131 | 2.020 |
Why?
|
Specimen Handling | 6 | 2024 | 706 | 1.870 |
Why?
|
Thyroid Nodule | 7 | 2023 | 765 | 1.710 |
Why?
|
Adenocarcinoma | 20 | 2024 | 6359 | 1.620 |
Why?
|
Thyroid Neoplasms | 11 | 2023 | 2355 | 1.590 |
Why?
|
Adenocarcinoma, Follicular | 5 | 2023 | 323 | 1.350 |
Why?
|
Laboratories | 3 | 2022 | 463 | 1.240 |
Why?
|
Molecular Diagnostic Techniques | 5 | 2023 | 614 | 1.230 |
Why?
|
Thyroid Gland | 6 | 2022 | 1170 | 1.160 |
Why?
|
Bronchoscopy | 10 | 2022 | 913 | 0.870 |
Why?
|
Pleural Effusion, Malignant | 1 | 2024 | 108 | 0.860 |
Why?
|
Lung | 17 | 2024 | 10067 | 0.810 |
Why?
|
Bronchi | 4 | 2021 | 847 | 0.760 |
Why?
|
Salivary Glands | 1 | 2022 | 231 | 0.730 |
Why?
|
Granuloma | 2 | 2020 | 329 | 0.670 |
Why?
|
Neoplasm Staging | 14 | 2024 | 11218 | 0.660 |
Why?
|
Receptor Protein-Tyrosine Kinases | 11 | 2022 | 1621 | 0.650 |
Why?
|
Antigens, CD1d | 2 | 2019 | 226 | 0.650 |
Why?
|
Mutation | 19 | 2024 | 30213 | 0.600 |
Why?
|
Societies, Scientific | 1 | 2019 | 221 | 0.600 |
Why?
|
Natural Killer T-Cells | 2 | 2019 | 319 | 0.590 |
Why?
|
Mediastinal Diseases | 1 | 2018 | 91 | 0.590 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2171 | 0.570 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2016 | 56 | 0.540 |
Why?
|
Quality Improvement | 4 | 2021 | 3850 | 0.540 |
Why?
|
Societies, Medical | 4 | 2023 | 3957 | 0.520 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 206 | 0.520 |
Why?
|
Tomography, X-Ray Computed | 20 | 2024 | 20708 | 0.470 |
Why?
|
Humans | 123 | 2024 | 766766 | 0.440 |
Why?
|
Diagnostic Errors | 3 | 2022 | 1276 | 0.420 |
Why?
|
Protein Kinase Inhibitors | 14 | 2023 | 5690 | 0.410 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 789 | 0.410 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 904 | 0.400 |
Why?
|
Pathology, Surgical | 2 | 2021 | 147 | 0.400 |
Why?
|
Carcinoma, Papillary | 2 | 2021 | 791 | 0.400 |
Why?
|
Pathology, Clinical | 3 | 2022 | 374 | 0.400 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2020 | 174 | 0.400 |
Why?
|
Heart Valve Diseases | 2 | 2021 | 1029 | 0.400 |
Why?
|
Receptors, LDL | 2 | 2019 | 492 | 0.390 |
Why?
|
Small Cell Lung Carcinoma | 4 | 2020 | 454 | 0.380 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1741 | 0.380 |
Why?
|
Lymph Nodes | 3 | 2018 | 3468 | 0.370 |
Why?
|
Atherosclerosis | 4 | 2019 | 3420 | 0.370 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1117 | 0.360 |
Why?
|
Laboratories, Hospital | 3 | 2021 | 192 | 0.360 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1895 | 0.360 |
Why?
|
Molecular Targeted Therapy | 4 | 2018 | 2823 | 0.360 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2019 | 281 | 0.360 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3666 | 0.350 |
Why?
|
Internet | 1 | 2022 | 3113 | 0.350 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2022 | 2510 | 0.340 |
Why?
|
Arteriosclerosis | 2 | 2005 | 1055 | 0.340 |
Why?
|
Retrospective Studies | 32 | 2024 | 81635 | 0.330 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2839 | 0.330 |
Why?
|
Endosonography | 3 | 2020 | 626 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2018 | 562 | 0.310 |
Why?
|
Cholesterol, VLDL | 1 | 2008 | 70 | 0.310 |
Why?
|
Immunohistochemistry | 9 | 2024 | 11061 | 0.290 |
Why?
|
Practice Guidelines as Topic | 6 | 2017 | 7431 | 0.290 |
Why?
|
Patient Care | 3 | 2023 | 629 | 0.290 |
Why?
|
Carcinoma | 2 | 2016 | 2324 | 0.290 |
Why?
|
Risk | 5 | 2023 | 9602 | 0.280 |
Why?
|
Calcinosis | 1 | 2015 | 1480 | 0.270 |
Why?
|
Prognosis | 12 | 2024 | 29948 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2948 | 0.260 |
Why?
|
Pneumonia | 1 | 2018 | 2159 | 0.260 |
Why?
|
Aged, 80 and over | 18 | 2024 | 59550 | 0.260 |
Why?
|
DNA Mutational Analysis | 4 | 2018 | 4114 | 0.260 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2022 | 520 | 0.260 |
Why?
|
Aged | 34 | 2024 | 171343 | 0.250 |
Why?
|
Aortic Valve | 1 | 2015 | 1966 | 0.250 |
Why?
|
Female | 54 | 2024 | 396520 | 0.240 |
Why?
|
Mediastinum | 2 | 2018 | 272 | 0.240 |
Why?
|
Lipoproteins | 3 | 2019 | 871 | 0.240 |
Why?
|
Precancerous Conditions | 1 | 2011 | 980 | 0.230 |
Why?
|
Argon Plasma Coagulation | 2 | 2021 | 26 | 0.230 |
Why?
|
Adoptive Transfer | 1 | 2007 | 828 | 0.230 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2019 | 5329 | 0.230 |
Why?
|
Male | 45 | 2024 | 364142 | 0.230 |
Why?
|
Gene Amplification | 3 | 2018 | 1088 | 0.230 |
Why?
|
Bronchial Neoplasms | 2 | 2014 | 109 | 0.220 |
Why?
|
Genetic Testing | 1 | 2017 | 3591 | 0.220 |
Why?
|
Biopsy, Needle | 5 | 2018 | 1615 | 0.220 |
Why?
|
Hemorheology | 1 | 2003 | 144 | 0.210 |
Why?
|
Amoeba | 1 | 2023 | 20 | 0.210 |
Why?
|
Aortic Valve Stenosis | 1 | 2015 | 2023 | 0.210 |
Why?
|
Aortic Diseases | 1 | 2008 | 741 | 0.200 |
Why?
|
Tracheobronchomalacia | 2 | 2021 | 131 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 6 | 2017 | 4522 | 0.200 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2018 | 1762 | 0.200 |
Why?
|
Pyrazoles | 4 | 2017 | 2030 | 0.190 |
Why?
|
Hand Deformities, Congenital | 1 | 2022 | 175 | 0.190 |
Why?
|
Middle Aged | 32 | 2024 | 223257 | 0.190 |
Why?
|
Curettage | 1 | 2021 | 74 | 0.180 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2021 | 88 | 0.180 |
Why?
|
Cell Biology | 1 | 2021 | 91 | 0.180 |
Why?
|
Fatal Outcome | 4 | 2020 | 1838 | 0.180 |
Why?
|
Carbazoles | 2 | 2022 | 230 | 0.180 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2017 | 2426 | 0.180 |
Why?
|
Pyridines | 4 | 2017 | 2888 | 0.170 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2007 | 1802 | 0.170 |
Why?
|
Biopsy | 4 | 2024 | 6779 | 0.170 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2020 | 55 | 0.160 |
Why?
|
Tracheal Stenosis | 1 | 2021 | 228 | 0.160 |
Why?
|
Total Quality Management | 1 | 2020 | 264 | 0.160 |
Why?
|
Neoplasms | 3 | 2022 | 22350 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9404 | 0.160 |
Why?
|
Pulmonary Sclerosing Hemangioma | 1 | 2018 | 2 | 0.160 |
Why?
|
Myositis | 1 | 2021 | 268 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2007 | 2210 | 0.150 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2937 | 0.150 |
Why?
|
Tumor Burden | 3 | 2020 | 1900 | 0.150 |
Why?
|
Truth Disclosure | 1 | 2022 | 433 | 0.150 |
Why?
|
Pleurodesis | 1 | 2018 | 49 | 0.150 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2024 | 616 | 0.150 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2901 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2023 | 497 | 0.140 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 755 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2024 | 492 | 0.140 |
Why?
|
Trachea | 2 | 2021 | 1094 | 0.140 |
Why?
|
Genomics | 4 | 2024 | 5923 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2022 | 857 | 0.140 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15416 | 0.140 |
Why?
|
Microscopy, Fluorescence | 1 | 2024 | 2629 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 828 | 0.140 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 209 | 0.140 |
Why?
|
Radiography, Interventional | 1 | 2024 | 1129 | 0.140 |
Why?
|
Adult | 22 | 2024 | 223307 | 0.140 |
Why?
|
Thorax | 1 | 2020 | 555 | 0.140 |
Why?
|
Antineoplastic Agents | 9 | 2018 | 13643 | 0.140 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2021 | 391 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2021 | 575 | 0.140 |
Why?
|
Needles | 1 | 2020 | 462 | 0.140 |
Why?
|
Leukocytes | 1 | 2005 | 2035 | 0.140 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 403 | 0.140 |
Why?
|
Exons | 2 | 2023 | 2392 | 0.140 |
Why?
|
Adaptive Immunity | 2 | 2019 | 734 | 0.130 |
Why?
|
Organ Specificity | 2 | 2016 | 1966 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14652 | 0.130 |
Why?
|
False Positive Reactions | 1 | 2018 | 957 | 0.130 |
Why?
|
Genes, erbB-1 | 1 | 2017 | 161 | 0.130 |
Why?
|
Chondrosarcoma | 1 | 2018 | 305 | 0.130 |
Why?
|
Benchmarking | 1 | 2022 | 1056 | 0.130 |
Why?
|
Carotid Artery, Internal | 1 | 2018 | 440 | 0.120 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 21 | 0.120 |
Why?
|
HIV | 2 | 2023 | 1588 | 0.120 |
Why?
|
Airway Obstruction | 1 | 2020 | 672 | 0.120 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3609 | 0.120 |
Why?
|
Workload | 1 | 2020 | 849 | 0.120 |
Why?
|
Baths | 1 | 2014 | 52 | 0.120 |
Why?
|
Tissue Preservation | 1 | 2015 | 170 | 0.120 |
Why?
|
Metaplasia | 1 | 2015 | 326 | 0.120 |
Why?
|
Gene Rearrangement | 2 | 2017 | 1142 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2018 | 678 | 0.110 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 82 | 0.110 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2014 | 62 | 0.110 |
Why?
|
Autopsy | 1 | 2018 | 1011 | 0.110 |
Why?
|
Water Microbiology | 1 | 2014 | 117 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 447 | 0.110 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2013 | 22 | 0.110 |
Why?
|
Watchful Waiting | 1 | 2018 | 492 | 0.110 |
Why?
|
Sputum | 1 | 2016 | 514 | 0.110 |
Why?
|
Piperidines | 2 | 2022 | 1663 | 0.110 |
Why?
|
United States | 6 | 2023 | 72951 | 0.110 |
Why?
|
Tablets | 1 | 2014 | 149 | 0.110 |
Why?
|
Mesothelioma | 1 | 2019 | 774 | 0.110 |
Why?
|
Amyloidosis | 1 | 2021 | 877 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18330 | 0.110 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1828 | 0.100 |
Why?
|
Respiratory Aspiration | 1 | 2014 | 89 | 0.100 |
Why?
|
Pulmonary Atelectasis | 1 | 2014 | 160 | 0.100 |
Why?
|
Dyspnea | 2 | 2018 | 1352 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 939 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2023 | 1463 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 698 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.100 |
Why?
|
SEER Program | 1 | 2017 | 1443 | 0.100 |
Why?
|
Hypercalcemia | 1 | 2014 | 425 | 0.100 |
Why?
|
Esophagitis | 1 | 2013 | 163 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4049 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2043 | 0.100 |
Why?
|
Formaldehyde | 2 | 2024 | 360 | 0.090 |
Why?
|
Thymoma | 1 | 2013 | 186 | 0.090 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 670 | 0.090 |
Why?
|
ras Proteins | 2 | 2013 | 1055 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2019 | 14471 | 0.090 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1414 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1101 | 0.090 |
Why?
|
Sirolimus | 1 | 2018 | 1540 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 594 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2881 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 343 | 0.090 |
Why?
|
False Negative Reactions | 1 | 2011 | 570 | 0.090 |
Why?
|
Radiography, Thoracic | 4 | 2020 | 1320 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2015 | 1103 | 0.090 |
Why?
|
Adenoma, Oxyphilic | 1 | 2012 | 151 | 0.090 |
Why?
|
Cholesterol | 1 | 2019 | 2903 | 0.090 |
Why?
|
Myasthenia Gravis | 1 | 2013 | 214 | 0.090 |
Why?
|
Strongyloidiasis | 1 | 2010 | 27 | 0.090 |
Why?
|
Child | 4 | 2023 | 80668 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22352 | 0.090 |
Why?
|
Jejunal Diseases | 1 | 2010 | 45 | 0.090 |
Why?
|
Terminology as Topic | 2 | 2021 | 1540 | 0.080 |
Why?
|
Duodenal Diseases | 1 | 2010 | 101 | 0.080 |
Why?
|
Foreign Bodies | 1 | 2014 | 403 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6850 | 0.080 |
Why?
|
Schistosomiasis mansoni | 1 | 2010 | 94 | 0.080 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 306 | 0.080 |
Why?
|
Diverticulum | 1 | 2010 | 137 | 0.080 |
Why?
|
Mice | 9 | 2019 | 81889 | 0.080 |
Why?
|
Diet, Atherogenic | 1 | 2008 | 92 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1403 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2039 | 0.080 |
Why?
|
Immunocompetence | 1 | 2008 | 138 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1271 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3561 | 0.080 |
Why?
|
Sheep | 2 | 2021 | 1448 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1061 | 0.070 |
Why?
|
Communication | 1 | 2022 | 3905 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2020 | 65273 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11872 | 0.070 |
Why?
|
Animals | 13 | 2021 | 168930 | 0.070 |
Why?
|
Risk Factors | 5 | 2015 | 74881 | 0.070 |
Why?
|
Disease Progression | 5 | 2020 | 13640 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6558 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9547 | 0.070 |
Why?
|
Heart Valve Prosthesis | 1 | 2015 | 1464 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2597 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1123 | 0.070 |
Why?
|
Myocarditis | 1 | 2014 | 802 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 12985 | 0.070 |
Why?
|
Thyroidectomy | 1 | 2012 | 912 | 0.060 |
Why?
|
Pyrimidines | 1 | 2018 | 3043 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2017 | 5306 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2014 | 1938 | 0.060 |
Why?
|
Models, Animal | 2 | 2020 | 2121 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.060 |
Why?
|
Genotype | 3 | 2015 | 13036 | 0.060 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4891 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1564 | 0.060 |
Why?
|
Young Adult | 4 | 2019 | 59939 | 0.060 |
Why?
|
HIV Infections | 2 | 2023 | 17536 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1960 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2005 | 313 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2024 | 303 | 0.050 |
Why?
|
Tissue Fixation | 1 | 2024 | 245 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1126 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2014 | 1481 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4747 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9346 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2018 | 17088 | 0.050 |
Why?
|
Immune System | 1 | 2007 | 800 | 0.050 |
Why?
|
Suction | 1 | 2023 | 268 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 2008 | 1812 | 0.050 |
Why?
|
Hyperlipidemias | 1 | 2007 | 771 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2326 | 0.050 |
Why?
|
Facies | 1 | 2022 | 224 | 0.050 |
Why?
|
Aniline Compounds | 2 | 2019 | 1079 | 0.050 |
Why?
|
Argon | 1 | 2021 | 36 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 97 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2021 | 109 | 0.050 |
Why?
|
Smad4 Protein | 1 | 2022 | 193 | 0.050 |
Why?
|
Pneumothorax | 1 | 2024 | 393 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5536 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4215 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 193 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2596 | 0.050 |
Why?
|
Triglycerides | 1 | 2008 | 2441 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2929 | 0.040 |
Why?
|
Planning Techniques | 1 | 2020 | 81 | 0.040 |
Why?
|
Smoking | 2 | 2017 | 9077 | 0.040 |
Why?
|
Papillary Muscles | 1 | 2021 | 192 | 0.040 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12825 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2024 | 723 | 0.040 |
Why?
|
Elastin | 1 | 2021 | 299 | 0.040 |
Why?
|
Electrocoagulation | 1 | 2020 | 156 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 50 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4570 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20144 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 40149 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 132 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2008 | 2392 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1103 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 97 | 0.040 |
Why?
|
Adolescent | 4 | 2019 | 88904 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4353 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 426 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 591 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15835 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1313 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2008 | 2645 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 183 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2021 | 505 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2021 | 1131 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39309 | 0.040 |
Why?
|
Acrylamides | 1 | 2019 | 260 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2011 | 3077 | 0.040 |
Why?
|
Inflammation | 2 | 2021 | 10860 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1010 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1612 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8728 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1711 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 388 | 0.030 |
Why?
|
World Health Organization | 1 | 2023 | 1327 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1791 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 598 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5890 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 957 | 0.030 |
Why?
|
Incidental Findings | 1 | 2021 | 698 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5861 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 871 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 238 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2021 | 1026 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8621 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1228 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 932 | 0.030 |
Why?
|
Models, Biological | 2 | 2018 | 9461 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2023 | 1342 | 0.030 |
Why?
|
Medical Errors | 1 | 2022 | 1260 | 0.030 |
Why?
|
Capnography | 1 | 2014 | 90 | 0.030 |
Why?
|
Phosphorylation | 2 | 2015 | 8307 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9101 | 0.030 |
Why?
|
Radiography | 2 | 2015 | 6968 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 638 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 412 | 0.030 |
Why?
|
Luciferases | 1 | 2015 | 713 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3158 | 0.030 |
Why?
|
Video-Assisted Surgery | 1 | 2013 | 51 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2077 | 0.030 |
Why?
|
Risk Assessment | 3 | 2023 | 24295 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2115 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1263 | 0.030 |
Why?
|
Mitral Valve | 1 | 2021 | 1473 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2003 | 3139 | 0.020 |
Why?
|
Thymectomy | 1 | 2013 | 200 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4853 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 492 | 0.020 |
Why?
|
Cytokines | 1 | 2007 | 7438 | 0.020 |
Why?
|
Carboplatin | 1 | 2015 | 789 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 349 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 572 | 0.020 |
Why?
|
Polypharmacy | 1 | 2014 | 307 | 0.020 |
Why?
|
Genomic Instability | 1 | 2015 | 716 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2902 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2614 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2470 | 0.020 |
Why?
|
Strongyloides stercoralis | 1 | 2010 | 23 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3607 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1566 | 0.020 |
Why?
|
Sex Factors | 1 | 2003 | 10619 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2045 | 0.020 |
Why?
|
Waiting Lists | 1 | 2014 | 779 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2846 | 0.020 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2519 | 0.020 |
Why?
|
Cryosurgery | 1 | 2014 | 478 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7585 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1367 | 0.020 |
Why?
|
Signal Transduction | 3 | 2018 | 23619 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1405 | 0.020 |
Why?
|
Hot Temperature | 1 | 2014 | 1442 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1609 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2014 | 640 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 1231 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3587 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5022 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12791 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54871 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8045 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3624 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1241 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5748 | 0.020 |
Why?
|
Ultrasonography | 1 | 2018 | 5992 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1982 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2827 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4142 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6066 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6512 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10745 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18984 | 0.010 |
Why?
|
Immunization | 1 | 2007 | 1218 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8507 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4251 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2014 | 2416 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2024 | 15831 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3771 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8735 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5199 | 0.010 |
Why?
|
Vitamin D | 1 | 2014 | 3270 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15563 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41710 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15908 | 0.010 |
Why?
|
Schizophrenia | 1 | 2014 | 6976 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4784 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16724 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11513 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42577 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10264 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21162 | 0.000 |
Why?
|